OREANDA-NEWS. SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN, OTCPK: SMDCY) (“SHL”), a leading provider and developer of advanced personal telemedicine solutions, announced today that an Annual General Meeting of the Shareholders will be held on February 24, 2016 at 13:00 p.m. (Israel Time), at the Company’s registered office, located at 90 Yigal Alon Street, Ashdar Building, Tel-Aviv, Israel. The agenda shall include the following matters:

  1. Presentation and discussion of the Company’s financial statements for the fiscal year ending December 31, 2014, as approved by the Board of Directors of the Company (the “Board”) on March 24, 2015.
  2. The re-appointment of Kost, Forer, Gabbay & Kasierer (members of Ernst & Young Global) as the external auditors of the Company (including for the fiscal year 2015), to serve until the next annual general meeting, and authorization to the Board to determine the remuneration of such external auditors and the other terms and conditions of their engagement.
  3. Election of directors: election of up to seven directors to the Board out of seven proposed candidates, who shall serve as directors of the Company until the next annual general meeting. The current candidates are: Mr. Amnon Sorek, Mr. Eli Alroy, Mr. Uzi Blumensohn, Mr. Eyal Bakshi, Dr. Amir Lerman, Mr. Elon Shalev and Mr. Erez Alroy.
  4. Approval of the payment of monetary compensation to the Company’s Chairman of the Board, as elected by the Board following the AGM, effective as of the time of such election and for as long as such person serves as Chairman of the Board (instead of and not in addition to regular director compensation (to the extent approved)); and all provided that such Chairman is not a controlling shareholder of the Company or such controlling shareholders’ relative (as such terms are defined under the Israeli Companies Law) and further provided that the payment of the proposed Chairman compensation would not otherwise constitute a transaction under Section 270(4) of the Companies Law.
  5. Approval of Option Grant to Mr. Ziv Carthy, a director of the Company.
  6. Approval of compensation to Mr. Uzi Blumensohn, a director of the Company, for the time period from his election on December 3, 2015 until this AGM (only to the extent legally required).

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. The Company operates in Israel, Germany, India and the United States in one business segment, Telemedicine services. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and has an ADR program listed over-the counter; Symbol: SMDCY.